This is a clinical trial that includes a run-in period, a 90 day micro-randomized trial, and a 90-day observational period. The goal of this study is to evaluate whether providing paired real time glycemic and health behavior data in a smartphone app leads to better glycemic control among adolescents and young adults with T2D. Glycemic control will be monitored using Continuous Glucose Monitors (CGM), and health behavior data will be collected via a Fitbit activity tracker and a research app (Healthmine). Participants will be prompted to view and reflect on glycemic trends and health behavior data (Fitbit data, logging of diet and medication adherence) during the 90-day micro-randomized trial period, then observed for ongoing use of the Healthmine app and engagement with CGM in the following 90-day observation period.
Age range
16 Years – 24 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Glucose time above 180mg/dL
Timeframe: daily during micro randomized trial, 90 days
Mean daily glucose
Timeframe: daily during micro randomized trial, 90 days
Maximum daily glucose
Timeframe: daily during micro randomized trial, 90 days
Minimum daily glucose
Timeframe: daily during micro randomized trial, 90 days
Glucose coefficient of variability
Timeframe: daily during micro randomized trial, 90 days
Mean amplitude of glycemic excursions
Timeframe: daily during micro randomized trial, 90 days
Hemoglobin A1c
Timeframe: through study completion, 6 months average
Fasting glucose
Timeframe: through study completion, 6 months average
Objective physical activity (step count)
Timeframe: daily during micro randomized trial, 90 days;
Objective physical activity (moderate-vigorous physical activity)
Timeframe: daily during micro randomized trial, 90 days;
Self-reported physical activity
Timeframe: through study completion, 6 months average
Diet quality
Timeframe: through study completion, 6 months average
Capability
Timeframe: through study completion, 6 months average
Healthmine app use
Timeframe: during microrandomized trial, observational period
Continuous glucose monitor use use
Timeframe: during microrandomized trial, observational period
Motivation to engage in diabetes self-management
Timeframe: through study completion, 6 months average